Page last updated: 2024-11-03

prazosin and Respiratory Distress Syndrome

prazosin has been researched along with Respiratory Distress Syndrome in 1 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yu, Z1
Saito, H1
Otsuka, H1
Shikama, Y1
Funayama, H1
Sakai, M1
Murai, S1
Nakamura, M1
Yokochi, T1
Takada, H1
Sugawara, S1
Endo, Y1

Other Studies

1 other study available for prazosin and Respiratory Distress Syndrome

ArticleYear
Pulmonary platelet accumulation induced by catecholamines: Its involvement in lipopolysaccharide-induced anaphylaxis-like shock.
    International immunopharmacology, 2017, Volume: 43

    Topics: Anaphylaxis; Animals; Blood Platelets; Catecholamines; Cells, Cultured; Complement C5; Humans; Lipop

2017